Blog


Understanding State Laws for Interchangeable Biosimilars

October 15, 2021

An important development in the biopharmaceutical world, with significant ramifications for patients, is the progress being made on biosimilars.  These are products with the same safety and efficacy as FDA-approved … Continued


The Problematic Push to Slow Medicare Advantage’s Positive Health Impact

September 23, 2021

In the complex deliberations on Capitol Hill to assemble a social spending package that can pass both houses, one of the prominent proposals being discussed is the expansion of Medicare … Continued


Addressing Children’s Behavioral Health Through School Telehealth Programs

August 25, 2021

Children are the future, however what does the future hold for our children? The CDC estimates that as many as one out of five children experience a mental disorder in … Continued


Investing in Non-Traditional Access to Care

May 25, 2021

Even before COVID-19, our healthcare system was evolving to expand remote and in-home care.  The pandemic has underscored the importance of providing quality care to people where they are. Leading … Continued


Merck for Mothers Continues to Advance Maternal Health Equity

April 30, 2021

In a nation where Black women are disproportionately impacted by maternal mortality; Merck for Mothers has committed to understanding women’s experiences in order to improve the quality of maternity care. … Continued


Health Industry Leader Offers a Medicare Advantage Solution

February 4, 2021

Politically, the notion of “Medicare for All” is a non-starter. Americans have consistently resisted the idea of a major government health coverage expansion that would take away the private plans … Continued


Let the Public Option Rest in Peace

August 24, 2016

Most will remember that one of the most spirited debates during congressional consideration of the Affordable Care Act, back in the early days of the Obama administration, concerned the proposed … Continued


Campaigns, Honesty and the Future of Medicare

August 17, 2016

It’s like a bad rerun, but one with real consequences.  Every two years, some political candidates and the interest groups that support them decide the best way to boost their … Continued


A Decade of Proving Critics Wrong

July 27, 2016

As it was enacted into law in 2003, the Medicare prescription drug benefit, which would come to be known as Medicare Part D, had no shortage of critics.  A New … Continued


An Innovation-Centric Approach to Pricing and Accessibility

July 7, 2016

“Policy should not lose sight of the fact that new treatments represent miracles to many patients, and should encourage more, not less innovation.” With those words in her op-ed in … Continued